The growing burden of non-communicable disease among persons living with HIV in Zimbabwe
File(s)00002030-201803270-00011.pdf (794.01 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Objectives:
We aim to characterize the future noncommunicable disease (NCD)
burden in Zimbabwe to identify future health system priorities.
Methods:
We developed an individual-based multidisease model for Zimbabwe,
simulating births, deaths, infection with HIV and progression and key NCD [asthma,
chronic kidney disease (CKD), depression, diabetes, hypertension, stroke, breast,
cervical, colorectal, liver, oesophageal, prostate and all other cancers]. The model
was parameterized using national and regional surveillance and epidemiological data.
Demographic and NCD burden projections were generated for 2015 to 2035.
Results:
The model predicts that mean age of PLHIV will increase from 31 to 45 years
between 2015 and 2035 (compared with 20 –26 in uninfected individuals). Conse-
quently, the proportion suffering from at least one key NCD in 2035 will increase by
26% in PLHIV and 6% in uninfected. Adult PLHIV will be twice as likely to suffer from at
least one key NCD in 2035 compared with uninfected adults; with 15.2% of all key
NCDs diagnosed in adult PLHIV, whereas contributing only 5% of the Zimbabwean
population. The most prevalent NCDs will be hypertension, CKD, depression and
cancers. This demographic and disease shift in PLHIV is mainly because of reductions in
incidence and the success of ART scale-up leading to longer life expectancy, and to a
lesser extent, the cumulative exposure to HIV and ART.
Conclusion:
NCD services will need to be expanded in Zimbabwe. They will need to
be integrated into HIV care programmes, although the growing NCD burden amongst
uninfected individuals presenting opportunities for additional services developed
within HIV care to benefit HIV-negative persons.
We aim to characterize the future noncommunicable disease (NCD)
burden in Zimbabwe to identify future health system priorities.
Methods:
We developed an individual-based multidisease model for Zimbabwe,
simulating births, deaths, infection with HIV and progression and key NCD [asthma,
chronic kidney disease (CKD), depression, diabetes, hypertension, stroke, breast,
cervical, colorectal, liver, oesophageal, prostate and all other cancers]. The model
was parameterized using national and regional surveillance and epidemiological data.
Demographic and NCD burden projections were generated for 2015 to 2035.
Results:
The model predicts that mean age of PLHIV will increase from 31 to 45 years
between 2015 and 2035 (compared with 20 –26 in uninfected individuals). Conse-
quently, the proportion suffering from at least one key NCD in 2035 will increase by
26% in PLHIV and 6% in uninfected. Adult PLHIV will be twice as likely to suffer from at
least one key NCD in 2035 compared with uninfected adults; with 15.2% of all key
NCDs diagnosed in adult PLHIV, whereas contributing only 5% of the Zimbabwean
population. The most prevalent NCDs will be hypertension, CKD, depression and
cancers. This demographic and disease shift in PLHIV is mainly because of reductions in
incidence and the success of ART scale-up leading to longer life expectancy, and to a
lesser extent, the cumulative exposure to HIV and ART.
Conclusion:
NCD services will need to be expanded in Zimbabwe. They will need to
be integrated into HIV care programmes, although the growing NCD burden amongst
uninfected individuals presenting opportunities for additional services developed
within HIV care to benefit HIV-negative persons.
Date Issued
2018-03-27
Date Acceptance
2018-01-04
Citation
AIDS, 2018, 32, pp.773-782
ISSN
0269-9370
Publisher
Lippincott, Williams & Wilkins
Start Page
773
End Page
782
Journal / Book Title
AIDS
Volume
32
Copyright Statement
Q 2018 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the
terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and
share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and
share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Sponsor
Medical Research Council (MRC)
Bill & Melinda Gates Foundation
Civilian Research & Development Foundation Golbal
Grant Number
MR/K010174/1B
OPP1084364
OISE-9531011
Subjects
06 Biological Sciences
11 Medical And Health Sciences
17 Psychology And Cognitive Sciences
Virology
Publication Status
Published